Skip to content

Studies on Accumulation of (14C)-Mescaline in Brain Homogenates: Effects of Psychotropic and Other Agents

Nandkumar S. Shah, Om D. Gulati

Pharmacology 1975 DOI: 10.1159/000136916 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Experimental study Peer reviewed
Population Rat brain homogenates
Interventions chlorpromazine trifluoperazine fluphenazine imipramine desmethylimipramine nortriptyline amitriptyline
Topics Mescaline
Keywords Imipramine Tricyclic Chlorpromazine Pharmacology Hallucinogen Phenothiazine Trifluoperazine Nortriptyline Fluphenazine Amitriptyline Plant-based medicinal research
Key findings High concentrations of tranquilizers and tricyclic antidepressants inhibit mescaline accumulation in rat brain pellets without affecting its metabolism, potentially explaining worsened hallucinogenic poisoning with tranquilizers.

Abstract

Incubation of rat brain homogenates or 14,500 g pellet isolated from the homogenate with (14C)-mescaline was associated with accumulation of (14C)-mescaline in the pellet. 1.33 mumol/ml of chlorpromazine, trifluoperazine, fluphenazine, imipramine, desmethylimipramine, nortriptyline and amitriptyline inhibited the accumulation of mescaline. Lower concentrations (0.133-0.44 mumol/ml) of the psychotropic drugs were less effective. The tricyclic antidepressants were less potent than the tranquilizers. Although the trimethoxyphenylacetic acid (TMPA) levels of the pellet were also reduced by the psychotropic drugs, the TMPA:mescaline ratios were unchanged indicating that the drugs had no effect on the metabolism of mescaline. The inhibition of accumulation of mescaline by the high concentrations of tranquilizers may divert more of the hallucinogen to the receptor site. Thus, an explanation for the reported worsening of clinical syndrome of hallucinogenic poisoning by tranquilizers is provided.

Comparable studies

Other experimental studies on mescaline, most cited first.

Explore topics